Discontinued — last reported Q4 '24
ResMed Net investment gains (losses) decreased by 3410.5% to -$10.13M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 79.4%, from -$5.65M to -$10.13M. Over 3 years (FY 2021 to FY 2025), Net investment gains (losses) shows a downward trend with a -10.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
High positive values reflect strong capital markets performance, but can create significant volatility in bottom-line earnings regardless of core operational health.
The net change in the value of a company's investment portfolio, including both realized gains from sales and unrealized...
Commonly scrutinized in the financial services and insurance sectors to separate investment performance from underwriting performance.
investment_gains_losses| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.63M | $5.61M | -$4.40M | -$1.74M | -$11.68M | -$3.28M | $8.37M | $6.42M | -$602.00K | -$1.89M | $13.92M | -$15.47M | -$680.00K | -$1.44M | -$5.65M | -$2.53M | -$6.19M | $306.00K | -$10.13M |
| QoQ Change | — | +54.7% | -178.5% | +60.6% | -572.9% | +71.9% | +355.1% | -23.3% | -109.4% | -213.6% | +837.2% | -211.2% | +95.6% | -111.6% | -292.4% | +55.1% | -144.4% | +104.9% | <-999% |
| YoY Change | — | — | — | — | -421.7% | -158.4% | +290.0% | +469.9% | +81.6% | -122.6% | +116.9% | — | -13.0% | +23.8% | -140.6% | +83.6% | -810.3% | +121.3% | -79.4% |